Achieve Life Sciences (STU:SP4P) Other Income (Expense) : €-0.55 Mil (TTM As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Achieve Life Sciences Other Income (Expense)?

Achieve Life Sciences's other income expense for the Achieve Life Sciences's pretax income for the three months ended in Mar. 2024 was €-0.06 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2024 was €-0.55 Mil.

Achieve Life Sciences Other Income (Expense) Historical Data

The historical data trend for Achieve Life Sciences's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Achieve Life Sciences Other Income (Expense) Chart

Achieve Life Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Income (Expense)

Get a 7-Day Free Trial

-0.03

-0.04

-0.07

0.04

-0.49

Achieve Life Sciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Income (Expense)	Get a 7-Day Free Trial															-	-0.01	-0.02	-0.47	-0.06

Achieve Life Sciences Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.55 Mil.

Achieve Life Sciences (STU:SP4P) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Achieve Life Sciences (STU:SP4P) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Achieve Life Sciences Inc (STU:SP4P) » Definitions » Other Income (Expense)

Comparable Companies

Traded in Other Exchanges

ACHV:USA SP4P:Germany

Address

22722 29th Dr. SE, Suite 1000, Bothell, WA, USA, 98021

Website

https://www.achievelifesciences.com

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the global smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for nicotine addiction.

Achieve Life Sciences (STU:SP4P) Headlines

No Headlines